Back to home
Trust Score: 30%

Trust Score calculated by AI analyzing study rigor, sample size (n), and the scientific source impact factor.

9/13/2026

Fasting activates AMPK and sirtuin pathways to remodel the epigenome, enhancing autophagy and stem cell function

Summary

Fasting activates AMPK and sirtuin signaling, leading to epigenomic remodeling that supports autophagy and stem cell maintenance.

AC
Adrian CastroEditorially reviewed

Adrian Castro created Biohacker Age to have a place to closely follow longevity and biological optimization research without relying on sensationalist headlines. Content is produced with AI assistance from scientific literature and is editorially reviewed before publishing.

About our methodology

The Numbers


Sample size: not applicable (review article). No new quantitative outcomes (e.g., % change, p‑value, effect size) were reported.

Context: What This Study Is


Harrath and colleagues from the Department of Zoology synthesized current literature on fasting‑induced epigenomic remodeling. The work appears as a narrative review in Mechanisms of Ageing and Development (2026). By collating findings from cellular, animal, and limited human investigations, the authors aimed to clarify how nutrient‑sensing pathways—principally AMPK and sirtuins—translate metabolic scarcity into chromatin‑level adaptations that support healthspan.

What This Result Means


Fasting triggers AMPK activation, which phosphorylates downstream targets that promote chromatin opening. Concurrently, sirtuin enzymes remove acetyl groups from histone tails, reshaping transcriptional programs toward catabolism, autophagy, and stem‑cell maintenance. The combined epigenomic shift curtails age‑related DNA‑methylation drift and dampens chronic inflammatory signaling. In essence, intermittent nutrient deprivation rewires the genome‑wide regulatory landscape, positioning cells to sustain function longer.

Study Limitations



  • Being a review, the article does not present original experimental data; conclusions rely on the quality and heterogeneity of cited studies.

  • Human evidence for fasting‑driven epigenomic changes remains sparse, with most mechanistic insights derived from rodent or cell‑culture models.

  • The low trust score (30/100) reflects limited peer‑review transparency and potential bias in source selection.

Practical Application


It is too early to prescribe a specific fasting regimen based solely on this review. Future work must deliver randomized controlled trials that directly measure AMPK activation, sirtuin‑mediated histone deacetylation, and epigenomic markers before and after defined fasting protocols in healthy adults. Only with such data can precise timing, duration, and frequency be recommended for performance optimization.



Disclaimer: This article is for informational and educational purposes only. The information presented does not constitute medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before modifying your diet, supplementation, or exercise routines. The scientific studies cited reflect the state of knowledge at their publication date and may be subject to revision.

Legal Notice

Medical Disclaimer: This content is for informational and educational purposes only. It is not intended to substitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or supplementation.

Science in your inbox

The most relevant studies of the week, curated and analyzed.

No spam. Unsubscribe anytime.